{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:39:40Z","timestamp":1781653180307,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10067-017-3722-6","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T13:38:26Z","timestamp":1498916306000},"page":"1699-1706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature"],"prefix":"10.1007","volume":"36","author":[{"given":"Gon\u00e7alo","family":"Boleto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustapha","family":"Dram\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Eschard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Hugues","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"issue":"9","key":"3722_CR1","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/ket414","volume":"53","author":"DE Furst","year":"2014","unstructured":"Furst DE, Emery P (2014) Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatol Oxf Engl. 53(9):1560\u20131569","journal-title":"Rheumatol Oxf Engl."},{"issue":"4","key":"3722_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/er.2007-0038","volume":"29","author":"J Lorenzo","year":"2008","unstructured":"Lorenzo J, Horowitz M, Choi Y (2008) Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29(4):403\u2013440","journal-title":"Endocr Rev"},{"issue":"1","key":"3722_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncprheum0036","volume":"1","author":"G Schett","year":"2005","unstructured":"Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS (2005) Mechanisms of disease: the link between RANKL and arthritic bone disease. Nat Clin Pract Rheumatol 1(1):47\u201354","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"3722_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5312\/wjo.v4.i1.1","volume":"4","author":"S Tanaka","year":"2013","unstructured":"Tanaka S (2013) Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways. World J Orthop 4(1):1\u20136","journal-title":"World J Orthop"},{"issue":"5","key":"3722_CR5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","volume":"159","author":"AR Pettit","year":"2001","unstructured":"Pettit AR, Ji H, von Stechow D, M\u00fcller R, Goldring SR, Choi Y et al (2001) TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159(5):1689\u20131699","journal-title":"Am J Pathol"},{"issue":"12","key":"3722_CR6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","volume":"66","author":"DA Hanley","year":"2012","unstructured":"Hanley DA, Adachi JD, Bell A, Brown V (2012) Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract 66(12):1139\u20131146","journal-title":"Int J Clin Pract"},{"issue":"8","key":"3722_CR7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u2013765","journal-title":"N Engl J Med"},{"issue":"9","key":"3722_CR8","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1210\/jc.2012-1569","volume":"97","author":"E Orwoll","year":"2012","unstructured":"Orwoll E, Teglbj\u00e6rg CS, Langdahl BL, Chapurlat R, Czerwinski E, Kendler DL et al (2012) A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density. J Clin Endocrinol Metab 97(9):3161\u20133169","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3722_CR9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","volume":"361","author":"MR Smith","year":"2009","unstructured":"Smith MR, Egerdie B, Hern\u00e1ndez Toriz N, Feldman R, Tammela TLJ, Saad F et al (2009) Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361(8):745\u2013755","journal-title":"N Engl J Med"},{"key":"3722_CR10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12891-015-0732-x","volume":"16","author":"K Takahashi","year":"2015","unstructured":"Takahashi K, Setoguchi T, Tawaratsumida H, Arishima Y, Tominaga H, Ishidou Y et al (2015) Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics. BMC Musculoskelet Disord 16:269","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"3722_CR11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14656566.2015.997709","volume":"16","author":"JN Hoes","year":"2015","unstructured":"Hoes JN, Bultink IEM, Lems WF (2015) Management of osteoporosis in rheumatoid arthritis patients. Expert Opin Pharmacother 16(4):559\u2013571","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"3722_CR12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT et al (2008) Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 58(5):1299\u20131309","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3722_CR13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/ard.2009.112920","volume":"69","author":"RK Dore","year":"2010","unstructured":"Dore RK, Cohen SB, Lane NE, Palmer W, Shergy W, Zhou L et al (2010) Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Ann Rheum Dis 69(5):872\u2013875","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3722_CR14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/acr.20004","volume":"62","author":"A Deodhar","year":"2010","unstructured":"Deodhar A, Dore RK, Mandel D, Schechtman J, Shergy W, Trapp R et al (2010) Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients. Arthritis Care Res 62(4):569\u2013574","journal-title":"Arthritis Care Res"},{"issue":"4","key":"3722_CR15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/acr.20172","volume":"62","author":"JT Sharp","year":"2010","unstructured":"Sharp JT, Tsuji W, Ory P, Harper-Barek C, Wang H, Newmark R (2010) Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis. Arthritis Care Res 62(4):537\u2013544","journal-title":"Arthritis Care Res"},{"issue":"Suppl 1","key":"3722_CR16","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar2166","volume":"9","author":"G Schett","year":"2007","unstructured":"Schett G (2007) Erosive arthritis. Arthritis Res Ther 9(Suppl 1):S2","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3722_CR17","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar2378","volume":"10","author":"UM D\u00f8hn","year":"2008","unstructured":"D\u00f8hn UM, Ejbjerg BJ, Hasselquist M, Narvestad E, M\u00f8ller J, Thomsen HS et al (2008) Detection of bone erosions in rheumatoid arthritis wrist joints with magnetic resonance imaging, computed tomography and radiography. Arthritis Res Ther. 10(1):R25","journal-title":"Arthritis Res Ther."},{"issue":"9","key":"3722_CR18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/ard.2009.114512","volume":"69","author":"A Fouque-Aubert","year":"2010","unstructured":"Fouque-Aubert A, Boutroy S, Marotte H, Vilayphiou N, Bacchetta J, Miossec P et al (2010) Assessment of hand bone loss in rheumatoid arthritis by high-resolution peripheral quantitative CT. Ann Rheum Dis 69(9):1671\u20131676","journal-title":"Ann Rheum Dis"},{"key":"3722_CR19","unstructured":"PRISMA [Internet]. [cited 2017 Feb 19]. Available from: http:\/\/www.prisma-statement.org\/"},{"key":"3722_CR20","unstructured":"PICO ontology | Cochrane Linked Data [Internet]. [cited 2017 Feb 19]. Available from: \/pico-ontology"},{"issue":"3","key":"3722_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3722_CR22","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3722_CR23","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/art.1780281203","volume":"28","author":"JT Sharp","year":"1985","unstructured":"Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M et al (1985) How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 28(12):1326\u20131335","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3722_CR24","first-page":"261","volume":"27","author":"D Heijde van der","year":"2000","unstructured":"van der Heijde D (2000) How to read radiographs according to the Sharp\/van der Heijde method. J Rheumatol 27(1):261\u2013263","journal-title":"J Rheumatol"},{"issue":"1","key":"3722_CR25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3722_CR26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","volume":"38","author":"DT Felson","year":"1995","unstructured":"Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C et al (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38(6):727\u2013735","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3722_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.1790050303","volume":"5","author":"DR Ramey","year":"1992","unstructured":"Ramey DR, Raynauld JP, Fries JF (1992) The health assessment questionnaire 1992: status and review. Arthritis Care Res Off J Arthritis Health Prof Assoc 5(3):119\u2013129","journal-title":"Arthritis Care Res Off J Arthritis Health Prof Assoc"},{"key":"3722_CR28","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions - Handbook4.2.6Sep2006.pdf [Internet]. [cited 2016 Feb 7]. Available from: http:\/\/community.cochrane.org\/sites\/default\/files\/uploads\/Handbook4.2.6Sep2006.pdf"},{"key":"3722_CR29","unstructured":"Takeuchi T, Tanaka Y, Ishiguro N, Yamanaka H, Yoneda T, Ohira T et al (2015) Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with rheumatoId arthritis on methotrexate to validate inhibitory effect on bone erosion (DRIVE)\u2014a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. Ann Rheum Dis 19"},{"key":"3722_CR30","doi-asserted-by":"crossref","unstructured":"Yue J (2016) Repair of bone erosion in rheumatoid arthritis by denosumab: a high-resolution peripheral quantitative computed tomography study. Arthritis Care Res Hoboken","DOI":"10.1002\/acr.23133"},{"key":"3722_CR31","unstructured":"Hasegawa T, Kaneko Y, Izumi K, Takeuchi T (2016) Efficacy of denosumab combined with bDMARDs on radiographic progression in rheumatoid arthritis. Jt Bone Spine Rev Rhum. 28"},{"issue":"9","key":"3722_CR32","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/rheumatology\/kes135","volume":"51","author":"C Gaujoux-Viala","year":"2012","unstructured":"Gaujoux-Viala C, Paternotte S, Combe B, Dougados M (2012) Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort. Rheumatol Oxf Engl 51(9):1648\u20131654","journal-title":"Rheumatol Oxf Engl"},{"issue":"11","key":"3722_CR33","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/art.21298","volume":"52","author":"B Svensson","year":"2005","unstructured":"Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafstr\u00f6m I (2005 Nov) Low-dose prednisolone in addition to the initial disease-modifying anti-rheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum 52(11):3360\u20133370","journal-title":"Arthritis Rheum"},{"key":"3722_CR34","unstructured":"AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Patients With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment - Full Text View - ClinicalTrials.gov [Internet]. [cited 2016 Jan 16]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01973569?term=denosumab+and+rheumatoid+arthritis&rank=2"},{"issue":"4","key":"3722_CR35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/ijr.15.24","volume":"10","author":"T Koike","year":"2015","unstructured":"Koike T, Inui K (2015) How can the treatment of rheumatoid arthritis be improved in Japan? Int J Clin Rheumatol 10(4):235\u2013244","journal-title":"Int J Clin Rheumatol"},{"issue":"3","key":"3722_CR36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Buch M, Burmester G, Dougados M et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying anti-rheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492\u2013509","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3722_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.22783","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC et al (2016) 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Care Res 68(1):1\u201325","journal-title":"Arthritis Care Res"},{"issue":"3","key":"3722_CR38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10067-010-1596-y","volume":"30","author":"CC Mok","year":"2011","unstructured":"Mok CC, Tam LS, Chan TH, Lee GKW, Li EKM (2011) Hong Kong Society of Rheumatology. Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology. Clin Rheumatol 30(3):303\u2013312","journal-title":"Clin Rheumatol"},{"key":"3722_CR39","volume":"6","author":"MA Lopez-Olivo","year":"2014","unstructured":"Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME (2014) Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev 6:CD000957","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"3722_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X12438080","volume":"4","author":"P Geusens","year":"2012","unstructured":"Geusens P (2012) The role of RANK ligand\/osteoprotegerin in rheumatoid arthritis. Ther Adv Musculoskelet Dis 4(4):225\u2013233","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"3722_CR41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/art.1780340606","volume":"34","author":"JT Sharp","year":"1991","unstructured":"Sharp JT, Wolfe F, Mitchell DM, Bloch DA (1991) The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum 34(6):660\u2013668","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3722_CR42","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.21678","volume":"54","author":"JS Smolen","year":"2006","unstructured":"Smolen JS, Van Der Heijde DMFM, St Clair EW, Emery P, Bathon JM, Keystone E et al (2006) Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 54(3):702\u2013710","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3722_CR43","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2008.094128","volume":"68","author":"JS Smolen","year":"2009","unstructured":"Smolen JS, van der Heijde DM, Aletaha D, Xu S, Han J, Baker D et al (2009) Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing. Ann Rheum Dis 68(10):1535\u20131340","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3722_CR44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jbspin.2005.10.019","volume":"73","author":"V Breuil","year":"2006","unstructured":"Breuil V, Euller-Ziegler L (2006) Bisphosphonate therapy in rheumatoid arthritis. Jt Bone Spine Rev Rhum 73(4):349\u2013354","journal-title":"Jt Bone Spine Rev Rhum"},{"issue":"6","key":"3722_CR45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/ar2877","volume":"11","author":"B Goff Le","year":"2009","unstructured":"Le Goff B, Soltner E, Charrier C, Maugars Y, R\u00e9dini F, Heymann D et al (2009) A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. Arthritis Res Ther 11(6):185","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3722_CR46","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.21824","volume":"54","author":"SJ Jarrett","year":"2006","unstructured":"Jarrett SJ, Conaghan PG, Sloan VS, Papanastasiou P, Ortmann C-E, O\u2019Connor PJ et al (2006) Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 54(5):1410\u20131414","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3722_CR47","first-page":"114","volume":"30","author":"H Valleala","year":"2012","unstructured":"Valleala H, Laasonen L, Koivula M-K, Risteli J, Konttinen YT (2012) Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritis. Clin Exp Rheumatol 30(1):114\u2013117","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"3722_CR48","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/art.20221","volume":"50","author":"MC Genovese","year":"2004","unstructured":"Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R et al (2004) Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum 50(5):1412\u20131419","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3722_CR49","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/art.39075","volume":"67","author":"JR Curtis","year":"2015","unstructured":"Curtis JR, Xie F, Yun H, Saag KG, Chen L, Delzell E (2015) Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab. Arthritis Rheumatol Hoboken NJ 67(6):1456\u20131464","journal-title":"Arthritis Rheumatol Hoboken NJ"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3722-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3722-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3722-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T08:58:26Z","timestamp":1659171506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3722-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3722-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,1]]}}}